Drag a card by its title · ⚙ to size, swap or remove

The company

Corbus Pharmaceuticals Holdings, Inc.

CRBP · Nasdaq

Health CareBiotechnologyNot moving yet

CRBP stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 6 weeks. It is 49.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 6
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $252K
Insider sales, 12 months: $2.3M
Officials’ trades on record: 0
Institutions holding: 107 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3

Sale orders, 12 months17

Buyers · sellers1 · 9

Who	Did	Shares	Traded
Yong BenDirector	sold	2,000at $7.84	14 Sep 2026filed 15 Sep 2026
Nishant C. SaxenaChief Business Officer	bought	2,600at $9.63	11 Aug 2026filed 12 Aug 2026
Sean F. MoranChief Financial Officer	sold	12,000at $10.08	7 Aug 2026filed 10 Aug 2026
Yuval CohenChief Executive Officer	sold	17,000at $10.08	7 Aug 2026filed 10 Aug 2026
Anne AltmeyerDirector	sold	2,412at $7.91	10 Jun 2026filed 11 Jun 2026
John Kenneth JenkinsDirector	sold	4,800at $7.91	10 Jun 2026filed 11 Jun 2026
Winston KungDirector	sold	2,026at $7.91	10 Jun 2026filed 11 Jun 2026
Nishant C. SaxenaChief Business Officer	bought	9,000at $7.58	3 Jun 2026filed 3 Jun 2026
Nishant C. SaxenaChief Business Officer	bought	4,500at $7.33	2 Jun 2026filed 3 Jun 2026
Dominic SmethurstChief Medical Officer	sold	6,097at $8.30	2 Mar 2026filed 4 Mar 2026
Ian HodgsonChief Operating Officer	sold	847at $7.38	17 Feb 2026filed 18 Feb 2026
Yuval CohenChief Executive Officer	sold	13,871at $7.78	13 Feb 2026filed 18 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders107+5 on the quarter

New · exited28 · 23

Reported value$129.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Cormorant Asset Management, LPunchanged · filed 14 Aug 2026	2,344,971$22.0M	00.0%
ORBIMED ADVISORS LLCunchanged · filed 14 Aug 2026	1,737,287$16.3M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	1,331,135$12.5M	+1,059,499+390.0%
Aberdeen Group plcunchanged · filed 31 Jul 2026	1,321,750$12.4M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	760,940$7.1M	+26,834+3.7%
Jones Hill Capital LPnew · filed 13 Aug 2026	653,572$6.1M	+653,572
Prosight Management, LPreduced · filed 14 Aug 2026	650,000$6.1M	-47,108−6.8%
Stonepine Capital Management, LLCadded · filed 14 Aug 2026	425,000$4.0M	+41,538+10.8%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	423,374$4.0M	+236,345+126.4%
ADAR1 Capital Management, LLCadded · filed 14 Aug 2026	421,787$4.0M	+90,006+27.1%